Early Changes in Ghrelin following Roux-en-Y Gastric Bypass: Influence of Vagal Nerve Functionality?
- Magnus SundbomAffiliated withDepartment of Surgical Sciences, University Hospital Email author
- , Camilla HoldstockAffiliated withDepartment of Medical Sciences/Internal Medicine, University Hospital
- , Britt Edén EngströmAffiliated withDepartment of Medical Sciences/Internal Medicine, University Hospital
- , F. Anders KarlssonAffiliated withDepartment of Medical Sciences/Internal Medicine, University Hospital
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Roux-en-Y gastric bypass (RYGBP) effectively produces massive weight reduction, improving health in morbidly obese patients. The mechanisms for the weight loss, and the fate of the excluded gastric mucosa, are not fully clarified. To what extent the appetite-stimulating gastric peptide ghrelin is affected remains controversial.
Circulating concentrations of ghrelin, pancreatic polypeptide (PP), pepsinogen I (PGI) and gastrin were examined in 15 morbidly obese patients (median BMI 45 kg/m2) preoperatively, and on days 1, 2, 4, 6 and at months 1, 6 and 12 after RYGBP.
Ghrelin levels fell on postoperative day 1 and increased after 1 month to preoperative levels, and rose further at 6 and 12 months. PP concentrations decreased on day 1 and subsequently returned to preoperative levels. PGI levels peaked transiently the first days after surgery and subsequently declined to lower than preoperative levels. Gastrin levels were gradually reduced postoperatively.
Ghrelin and PP fall transiently after surgery, possibly due to vagal dysfunction, and ultimately, as weight loss ensues, ghrelin secretion increases to higher than preoperative levels. The RYBGP procedure affects the gastric mucosa, as reflected by a transient increase in circulating PGI, and subsequently, the mucosa in the excluded stomach is at rest, as shown by low levels of PGI and gastrin.
Key wordsgastric bypass ghrelin pepsinogen gastrin pancreatic polypeptide morbid obesity vagus nerve
- Early Changes in Ghrelin following Roux-en-Y Gastric Bypass: Influence of Vagal Nerve Functionality?
Volume 17, Issue 3 , pp 304-310
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- gastric bypass
- pancreatic polypeptide
- morbid obesity
- vagus nerve
- Industry Sectors
- Author Affiliations
- 1. Department of Surgical Sciences, University Hospital, S-751 85, Uppsala, Sweden
- 2. Department of Medical Sciences/Internal Medicine, University Hospital, Uppsala, Sweden